ORIGINAL RESEARCH
Published on 17 Dec 2025
Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck
doi 10.3389/fimmu.2025.1664892
- 176 views
